Patent term extension in Japan: challenges still lay ahead even after the 2011 revision [0.03%]
日本医药品专利延期制度的完善仍有待时日——兼论2011年医药品和再生医疗产品法修正案的影响
Takeshi S Komatani
Takeshi S Komatani
Japan has a patent term extension (PTE) system similar to supplemental protection certificates in Europe and PTEs in the USA; however, the Japanese PTE system is different in many aspects. It is relatively known that it is not so difficult ...
Towards the ophthalmology patentome: a comprehensive patent database of ocular drugs and biomarkers [0.03%]
眼科专利组学：眼药和生物标志物的全面专利数据库
Hermann A M Mucke,Eva Mucke,Peter M Mucke
Hermann A M Mucke
We are currently building a database of all patent documents that contain substantial information related to pharmacology, drug delivery, tissue technology, and molecular diagnostics in ophthalmology. The goal is to establish a 'patentome',...
Ontology-based content analysis of US patent applications from 2001-2010 [0.03%]
基于本体的美国专利申请文本内容分析（2001-2010）
Lutz Weber,Timo Böhme,Matthias Irmer
Lutz Weber
Ontology-based semantic text analysis methods allow to automatically extract knowledge relationships and data from text documents. In this review, we have applied these technologies for the systematic analysis of pharmaceutical patents. Hie...
Katherine Kowalchyk,Cara Crowley-Weber
Katherine Kowalchyk
A comparison of the Hatch-Waxman Act for approval of small-molecule pharmaceuticals with the Biological Price Competition and Innovation Act for approval of biosimilars provides insight into the market entry and patent litigation for biosim...
Roche v. Cipla litigation [0.03%]
罗氏诉西普拉诉讼案
Meenakshi Khurana
Meenakshi Khurana
Why pharmaceutical scientists need to keep an eye on Bowman v. Monsanto [0.03%]
为什么医药科学家需要关注 Bowman vs.Monsanto案
Anthony J Trippe
Anthony J Trippe
Deborah L Lu,Thomas J Kowalski,Smitha B Uthaman et al.
Deborah L Lu et al.
Oncolytic virus therapies [0.03%]
溶瘤病毒疗法
Franco Maria Buonaguro,Maria Lina Tornesello,Francesco Izzo et al.
Franco Maria Buonaguro et al.
Oncolytic virus (OV) therapy currently represents one of the most promising approaches to cancer treatment for their dual anticancer mechanisms: direct lysis of cancer cells (oncolytic feature) and activation of the immunosystem (cancer vac...
Suzanne S Stokes,Marshall Morningstar,Helena Kocis et al.
Suzanne S Stokes et al.
This review summarizes patent applications from 2010 for small molecules for which there is a claim of antibacterial activity. The primary criterion for inclusion in this analysis was reporting of cellular antibacterial activity data (MICs)...
Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains [0.03%]
基于减毒脊灰沙宾疫苗株或新型替代种子株的创新脊灰灭活疫苗
Ahd Hamidi,Wilfried A M Bakker
Ahd Hamidi
This article gives an overview of the patent literature related to innovative inactivated polio vaccine (i-IPV) based on using Sabin poliovirus strains and newly developed alternative recombinant poliovirus strains. This innovative approach...